Could both indoor and outdoor air pollution significantly worsen respiratory health in patients with COPD? Find out.

In the United States, more than 10 million people above the age of 40 live with chronic obstructive pulmonary disease (COPD), a chronic lung disease that limits air flow and causes ...

In patients with COPD both with or without heart failure, AF episodes rise around the time patients are hospitalized for ...

When Sydney woman Linda Goldsmith started having trouble breathing around 15 years ago she put it down to moving house. It ...

Cardiac arrhythmias can produce a range of symptoms—from very mild, like lightheadedness, to life-threatening, including cardiac arrest. These can be divided into a “classic” group of symptoms that ...

They enrolled into a pair of late-stage trials nearly 1,900 people, all of whom were already receiving treatment with other COPD drugs. In both studies, Dupixent treatment was associated with a lower ...

Over the last decade, as other companies—such as AstraZeneca with IL-5 inhibitor Fasenra—struggled to advance candidates for COPD, Regeneron and Sanofi took a more “phenotype-driven approach ...

The U.S. Food and Drug Administration has approved Dupixent (dupilumab) to reduce COPD exacerbations in some patients whose symptoms aren’t adequately controlled with inhaled medicines.

The drug was cleared for use in adults whose COPD symptoms aren’t under control and whose disease is driven by eosinophils, a type of immune cell that can contribute to inflammation. There are ...

This approval was based on results from the phase 3 BOREAS (NCT03930732) and NOTUS (NCT04456673) trials, which demonstrated that dupilumab can significantly reduce COPD exacerbations. 2 The first ...

A lot of people with genital herpes don't know they have it. If you do, you might not have any symptoms or only have very mild ones. But because treatment can help prevent complications and make ...